Paloma Partners Management Co Makes New $939,000 Investment in Cardinal Health, Inc. $CAH

Key Points

• Paloma Partners Management Co has invested approximately $939,000 in Cardinal Health by acquiring 6,815 shares in the first quarter, reflecting a growing interest among institutional investors.
• Cardinal Health reported EPS of $2.08 for the last quarter, slightly above analysts' expectations, while projecting FY 2026 EPS guidance between 9.300 and 9.500.
• The company announced a quarterly dividend of $0.5107 per share, with a yield of 1.4%, scheduled to be paid to investors on October 15th.

Paloma Partners Management Co bought a new stake in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 6,815 shares of the company's stock, valued at approximately $939,000.

Several other institutional investors also recently bought and sold shares of the stock. Greykasell Wealth Strategies Inc. purchased a new stake in shares of Cardinal Health during the first quarter worth about $26,000. Tompkins Financial Corp boosted its holdings in shares of Cardinal Health by 106.7% during the first quarter. Tompkins Financial Corp now owns 248 shares of the company's stock worth $34,000 after purchasing an additional 128 shares during the period. GW&K Investment Management LLC boosted its holdings in shares of Cardinal Health by 113.4% during the first quarter. GW&K Investment Management LLC now owns 271 shares of the company's stock worth $37,000 after purchasing an additional 144 shares during the period. Measured Risk Portfolios Inc. purchased a new stake in shares of Cardinal Health during the fourth quarter worth about $47,000. Finally, NBC Securities Inc. purchased a new stake in shares of Cardinal Health during the first quarter worth about $48,000. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Stock Up 0.1%

Shares of CAH stock traded up $0.14 during trading hours on Friday, hitting $149.48. 1,715,434 shares of the company's stock traded hands, compared to its average volume of 2,643,307. The stock's fifty day simple moving average is $155.86 and its two-hundred day simple moving average is $146.83. Cardinal Health, Inc. has a 12-month low of $106.54 and a 12-month high of $168.44. The stock has a market cap of $35.69 billion, a price-to-earnings ratio of 23.17, a PEG ratio of 1.26 and a beta of 0.73.

Cardinal Health (NYSE:CAH - Get Free Report) last released its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.03 by $0.05. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The firm had revenue of $60.16 billion during the quarter, compared to analyst estimates of $60.91 billion. During the same period last year, the business earned $1.84 earnings per share. The business's revenue was up .5% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, equities analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be given a dividend of $0.5107 per share. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $2.04 annualized dividend and a dividend yield of 1.4%. Cardinal Health's dividend payout ratio (DPR) is 31.63%.

Insider Activity at Cardinal Health

In related news, CEO Stephen M. Mason sold 41,575 shares of the firm's stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the completion of the sale, the chief executive officer owned 26,085 shares of the company's stock, valued at $3,881,969.70. This trade represents a 61.45% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Michelle D. Greene sold 13,500 shares of the firm's stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the sale, the insider directly owned 14,976 shares of the company's stock, valued at $2,228,728.32. This trade represents a 47.41% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 271,676 shares of company stock valued at $40,489,525 over the last ninety days. Corporate insiders own 0.09% of the company's stock.

Wall Street Analysts Forecast Growth

CAH has been the subject of several research analyst reports. Jefferies Financial Group set a $150.00 price objective on shares of Cardinal Health in a report on Tuesday, August 12th. Wells Fargo & Company restated an "overweight" rating and issued a $185.00 price objective (up from $183.00) on shares of Cardinal Health in a report on Wednesday, August 13th. Wall Street Zen lowered shares of Cardinal Health from a "strong-buy" rating to a "buy" rating in a report on Saturday, August 2nd. Evercore ISI lowered their price objective on shares of Cardinal Health from $200.00 to $190.00 and set an "outperform" rating for the company in a report on Wednesday, August 13th. Finally, Bank of America raised their price objective on shares of Cardinal Health from $165.00 to $170.00 and gave the stock a "buy" rating in a report on Tuesday, June 10th. Twelve research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $165.93.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.